JP2024177207A5 - - Google Patents

Download PDF

Info

Publication number
JP2024177207A5
JP2024177207A5 JP2024167997A JP2024167997A JP2024177207A5 JP 2024177207 A5 JP2024177207 A5 JP 2024177207A5 JP 2024167997 A JP2024167997 A JP 2024167997A JP 2024167997 A JP2024167997 A JP 2024167997A JP 2024177207 A5 JP2024177207 A5 JP 2024177207A5
Authority
JP
Japan
Prior art keywords
vaccine composition
fragment
adjuvant
mic
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024167997A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024177207A (ja
Filing date
Publication date
Priority claimed from JP2018528691A external-priority patent/JP7099956B2/ja
Application filed filed Critical
Publication of JP2024177207A publication Critical patent/JP2024177207A/ja
Publication of JP2024177207A5 publication Critical patent/JP2024177207A5/ja
Pending legal-status Critical Current

Links

JP2024167997A 2015-12-04 2024-09-27 がんの治療のためのｍｉｃａ／ｂアルファ３ドメインによるワクチン接種 Pending JP2024177207A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201562263377P 2015-12-04 2015-12-04
US62/263,377 2015-12-04
US201662422454P 2016-11-15 2016-11-15
US62/422,454 2016-11-15
JP2018528691A JP7099956B2 (ja) 2015-12-04 2016-12-05 がんの治療のためのｍｉｃａ／ｂアルファ３ドメインによるワクチン接種
PCT/US2016/064969 WO2017096374A1 (en) 2015-12-04 2016-12-05 Vaccination with mica/b alpha 3 domain for the treatment of cancer
JP2022105405A JP7564842B2 (ja) 2015-12-04 2022-06-30 がんの治療のためのｍｉｃａ／ｂアルファ３ドメインによるワクチン接種

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022105405A Division JP7564842B2 (ja) 2015-12-04 2022-06-30 がんの治療のためのｍｉｃａ／ｂアルファ３ドメインによるワクチン接種

Publications (2)

Publication Number Publication Date
JP2024177207A JP2024177207A (ja) 2024-12-19
JP2024177207A5 true JP2024177207A5 (https=) 2025-07-04

Family

ID=57590885

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018528691A Active JP7099956B2 (ja) 2015-12-04 2016-12-05 がんの治療のためのｍｉｃａ／ｂアルファ３ドメインによるワクチン接種
JP2022105405A Active JP7564842B2 (ja) 2015-12-04 2022-06-30 がんの治療のためのｍｉｃａ／ｂアルファ３ドメインによるワクチン接種
JP2024167997A Pending JP2024177207A (ja) 2015-12-04 2024-09-27 がんの治療のためのｍｉｃａ／ｂアルファ３ドメインによるワクチン接種

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2018528691A Active JP7099956B2 (ja) 2015-12-04 2016-12-05 がんの治療のためのｍｉｃａ／ｂアルファ３ドメインによるワクチン接種
JP2022105405A Active JP7564842B2 (ja) 2015-12-04 2022-06-30 がんの治療のためのｍｉｃａ／ｂアルファ３ドメインによるワクチン接種

Country Status (24)

Country Link
US (3) US10993971B2 (https=)
EP (1) EP3383426A1 (https=)
JP (3) JP7099956B2 (https=)
KR (1) KR20180088458A (https=)
CN (1) CN108770343A (https=)
AU (3) AU2016362597C1 (https=)
BR (1) BR112018010705A8 (https=)
CA (1) CA3005910A1 (https=)
CL (3) CL2018001470A1 (https=)
CO (1) CO2018006642A2 (https=)
CR (2) CR20230116A (https=)
CU (2) CU24609B1 (https=)
EA (1) EA201891287A1 (https=)
IL (1) IL259490A (https=)
MX (2) MX2018006785A (https=)
MY (1) MY199248A (https=)
NZ (1) NZ742663A (https=)
PE (2) PE20181158A1 (https=)
PH (1) PH12018501170A1 (https=)
RU (2) RU2021109510A (https=)
SG (1) SG11201804597TA (https=)
TN (1) TN2018000187A1 (https=)
WO (1) WO2017096374A1 (https=)
ZA (1) ZA202204223B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210018205A (ko) 2018-04-03 2021-02-17 사노피 항원성 OspA 폴리펩타이드
EP3773698A1 (en) 2018-04-03 2021-02-17 Sanofi Ferritin proteins
WO2019195314A2 (en) 2018-04-03 2019-10-10 Sanofi Antigenic epstein barr virus polypeptides
JP7614841B2 (ja) 2018-04-03 2025-01-16 サノフイ 抗原性呼吸器合胞体ウイルスポリペプチド
US20240207385A1 (en) * 2020-02-26 2024-06-27 The Wistar Institute Of Anatomy And Biology Compositions comprising self-assembling vaccines and methods of using the same
KR20230152783A (ko) 2020-07-07 2023-11-03 칸큐어 엘엘씨 Mic 항체 및 결합제 및 이의 사용 방법
CN116396398B (zh) * 2023-01-16 2024-07-16 四川大学 一种实现铁蛋白纳米颗粒可控自组装的方法以及基于该方法搭建的纳米颗粒抗原展示平台
WO2024222886A1 (zh) * 2023-04-28 2024-10-31 北京先声祥瑞生物制品股份有限公司 一种针对MICA/B靶点的mRNA肿瘤疫苗

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4709017A (en) 1985-06-07 1987-11-24 President And Fellows Of Harvard College Modified toxic vaccines
US4950740A (en) 1987-03-17 1990-08-21 Cetus Corporation Recombinant diphtheria vaccines
DE3841091A1 (de) 1988-12-07 1990-06-13 Behringwerke Ag Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
CA2006700A1 (en) 1989-01-17 1990-07-17 Antonello Pessi Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
KR920703114A (ko) 1989-07-14 1992-12-17 원본미기재 접합체 백신을 위한 시토킨 및 호르몬 운반체
US5073627A (en) 1989-08-22 1991-12-17 Immunex Corporation Fusion proteins comprising GM-CSF and IL-3
IT1237764B (it) 1989-11-10 1993-06-17 Eniricerche Spa Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
SE466259B (sv) 1990-05-31 1992-01-20 Arne Forsgren Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
ATE128628T1 (de) 1990-08-13 1995-10-15 American Cyanamid Co Faser-hemagglutinin von bordetella pertussis als träger für konjugierten impfstoff.
IT1262896B (it) 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
CA2135052A1 (en) 1992-05-06 1993-11-11 R. John Collier Diphtheria toxin receptor-binding region
IL102687A (en) 1992-07-30 1997-06-10 Yeda Res & Dev Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
US6455673B1 (en) 1994-06-08 2002-09-24 President And Fellows Of Harvard College Multi-mutant diphtheria toxin vaccines
US5917017A (en) 1994-06-08 1999-06-29 President And Fellows Of Harvard College Diphtheria toxin vaccines bearing a mutated R domain
JP4469026B2 (ja) 1996-10-31 2010-05-26 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Ｓｔｒｅｐｔｏｃｏｃｃｕｓ ｐｎｅｕｍｏｎｉａｅの抗原およびワクチン
GB9713156D0 (en) 1997-06-20 1997-08-27 Microbiological Res Authority Vaccines
ATE459373T1 (de) 1999-03-19 2010-03-15 Glaxosmithkline Biolog Sa Impfstoff gegen kapsulare polysaccharide von streptococcus pneumoniae
JP2002541808A (ja) 1999-04-09 2002-12-10 テクラブ， インコーポレイテッド ポリサッカリド結合体ワクチンのための組換えトキシンａタンパク質キャリア
GB0007432D0 (en) 2000-03-27 2000-05-17 Microbiological Res Authority Proteins for use as carriers in conjugate vaccines
WO2002091998A2 (en) 2001-05-11 2002-11-21 Aventis Pasteur, Inc. Novel meningitis conjugate vaccine
CA2776391C (en) 2001-10-01 2015-03-31 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Development of a preventive vaccine for filovirus infection in primates
US6706305B2 (en) 2001-10-31 2004-03-16 Conagra Foods Inc. Low glycemic index bread
CN1659187A (zh) 2002-05-10 2005-08-24 新世纪药品有限公司 融合铁蛋白在疫苗和其他方面的应用
JP5525689B2 (ja) 2004-11-02 2014-06-18 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ セクレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ 過剰増殖性障害を処置するための組成物および方法
GB0428394D0 (en) 2004-12-24 2005-02-02 Chiron Srl Saccharide conjugate vaccines
US8110196B2 (en) 2005-04-29 2012-02-07 Polytopas LLC Methods and compositions for polytopic vaccination
US20070104689A1 (en) * 2005-09-27 2007-05-10 Merck Patent Gmbh Compositions and methods for treating tumors presenting survivin antigens
EP2083857A4 (en) 2006-09-22 2010-03-24 Dana Farber Cancer Res Inc METHOD FOR TREATING INTERFERENCE IN CONNECTION WITH MICA
US8182809B1 (en) * 2008-09-08 2012-05-22 University Of Washington Methods for treating cancer by inhibiting MIC shedding
WO2011046842A1 (en) 2009-10-12 2011-04-21 The Regents Of The University Of California Targeted nanoclusters and methods of their use
CN102656119B (zh) 2009-12-18 2015-11-25 花王株式会社 介孔二氧化硅颗粒的制造方法
JP5603063B2 (ja) 2009-12-21 2014-10-08 花王株式会社 複合シリカ粒子の製造方法
RU2489169C2 (ru) * 2010-10-12 2013-08-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Новосибирский национальный исследовательский государственный университет" (Новосибирский государственный университет, НГУ) Способ лечения онкологических заболеваний
AU2012311238A1 (en) * 2011-09-23 2014-04-17 University Of Oslo Vaccibodies targeted to cross-presenting dendritic cells
HUE034044T2 (en) 2011-09-30 2018-01-29 Dana Farber Cancer Inst Inc Therapeutic peptides
AU2013218017B2 (en) 2012-02-07 2017-12-07 Innate Pharma MICA binding agents
DK2838515T3 (da) 2012-04-16 2020-02-24 Harvard College Mesoporøse siliciumdioxidsammensætninger til modulering af immunresponser
SG11201506766PA (en) 2013-03-15 2015-09-29 Dana Farber Cancer Inst Inc Therapeutic peptides
EP2970490A4 (en) * 2013-03-15 2017-04-26 Novelogics Biotechnology, Inc. Antibodies to mica and micb proteins
CA2939006A1 (en) * 2014-03-14 2015-09-17 Dana-Farber Cancer Institute, Inc. Vaccine compositions and methods for restoring nkg2d pathway function against cancers

Similar Documents

Publication Publication Date Title
JP2024177207A5 (https=)
JP2022130623A5 (https=)
US10682402B2 (en) MSI-specific frameshift peptides (FSP) for prevention and treatment of cancer
JP7099956B2 (ja) がんの治療のためのｍｉｃａ／ｂアルファ３ドメインによるワクチン接種
JP2019515005A (ja) 水酸化アルミニウムゲル−塩化ナトリウム複合免疫学的アジュバント、並びにその調製方法及びその使用
CN104853764B (zh) 用于预防和治疗癌症的msi-特异性移码肽(fsp)
EP1844788B1 (en) HER-2/neu multi-peptide vaccine
US20190167788A1 (en) Composition and Method for Treating Cancer
EP2572725B1 (en) MSI-specific frameshift peptides (FSP) for prevention and treatment of cancer
EP1687023B1 (en) Use of specific histones for the treatment of parasitic diseases
US10137185B2 (en) PAP peptide analogues
JP2026501821A (ja) 免疫調節系としてメソポーラスシリカロッドを使用したサイトカインの腫瘍間送達および腫瘍内送達
EP1829893B1 (en) Immunotherapeutic formulations with interleukin-2-neutralising capacity
KR20250057646A (ko) Kras 면역원성 펩타이드
Fridman et al. The use of cytokines in the treatment of solid tumours
WO2026012340A1 (zh) CpG1018/1826/007/2006联合MNR的组合物用于治疗胰腺癌
RU2021115093A (ru) Противораковые вакцины, нацеленные на boris, и способы их применения
KR20090018968A (ko) 핵산 백신의 면역보강을 위한 ｐｐｄ의 용도